JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Frankle, W. G.
Right arrow Articles by Laruelle, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Frankle, W. G.
Right arrow Articles by Laruelle, M.

Estimation of Serotonin Transporter Parameters with 11C-DASB in Healthy Humans: Reproducibility and Comparison of Methods

W. Gordon Frankle1, Mark Slifstein1, Roger N. Gunn2, Yiyun Huang1,3, Dah-Ren Hwang1,3, E. Ashlie Darr1, Rajesh Narendran1, Anissa Abi-Dargham1,3 and Marc Laruelle1,3

1 Department of Psychiatry, Columbia University College of Physicians and Surgeons and the New York State Psychiatric Institute, New York, New York; 2 Translational Medicine and Genetics, GlaxoSmithKline, Greenford, United Kingdom; and 3 Department of Radiology, Columbia University College of Physicians and Surgeons and the New York State Psychiatric Institute, New York, New York


Figure 1
View larger version (11K):

[in a new window]
 
FIGURE 1.  (A) Mean ± SD of total plasma activity normalized to injected dose [Bq/(mL x MBq ID) after injection of 11C-DASB. Each point is mean of 9 subjects. After a rapid distribution, plasma activity stabilized to a relatively constant level. (B) Mean ± SD of fraction of plasma activity corresponding to parent compound after injection of 11C-DASB. Values are mean of 9 subjects. (C) Mean plasma activity corresponding to parent compound after injection of 11C-DASB. Each point is mean of 9 subjects.

 

Figure 2
View larger version (21K):

[in a new window]
 
FIGURE 2.  Regional time–activity curves measured after injection of 551.3 MBq 11C-DASB in 33-y-old female. Regions displayed include MID ({circ}), STR ({square}), MTL ({diamond}), MPFC ({triangleup}), and CER ({triangledown}). Points are measured activities in ROIs; lines are fitted values to 1TC model (solid line) and 2TC model (dashed line). Fits for both models are similar.

 

Figure 3
View larger version (10K):

[in a new window]
 
FIGURE 3.  Relationship between impulse response fraction (IRF) generated from kinetic 2TC data and model order chosen by DEPICT. In the case when the IRF is small (<0.005, below dashed horizontal line), model order is spread between 1TC and 2TC without clear bias toward one or the other. However, for IRF of >0.005, the DEPICT method settled nearly exclusively on the 2TC model. This is particularly evident for IRF of >0.01 (above solid horizontal line).

 





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2006 by the Society of Nuclear Medicine.